Test Price
2,100 AED✅ Home Collection Available
Amniotic Fluid Molecular Karyotyping Test in UAE | 2100 AED | 2026 DHA Guidelines
تحليل النمط النووي الجزيئي للسائل الأمنيوسي في الإمارات | 2100 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with our DHA-licensed obstetric genetics team.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (Arabic/English).
Overview
The Amniotic Fluid Molecular Karyotyping Test (also known as prenatal chromosomal microarray or high-resolution karyotype) detects submicroscopic deletions, duplications, and aneuploidies from cultured amniocytes using advanced molecular cytogenetics and culture-based karyotyping. In the UAE, it is the definitive invasive prenatal diagnostic procedure for fetal genetic conditions, offering comprehensive genomic coverage beyond standard G-banded karyotyping. تحليل النمط النووي الجزيئي للسائل الأمنيوسي هو الفحص الجيني قبل الولادة الأكثر شمولاً، ويكشف عن التغيرات الصبغية الدقيقة التي لا تظهر بالتحليل التقليدي.
| Feature | Our Test (Molecular Karyotyping) | Standard Karyotype (G-Banding) |
|---|---|---|
| Resolution | ≥ 50 kb (detects microdeletions/duplications) | 5–10 Mb (large structural anomalies only) |
| Methodology | Cell Culture + Chromosomal Microarray (CMA) / aCGH, confirmed by karyotyping | Cell Culture + Giemsa Banding & Microscopy |
| Turnaround Time | 7–9 Days | 14–21 Days |
| Diagnostic Yield | Increases detection of pathogenic CNVs by ~6% over karyotype in fetuses with structural anomalies | Lower resolution; misses many microdeletion syndromes |
Physician Insight & Safety Protocol
“As a DHA-licensed specialist, I emphasize that this test provides unparalleled genomic detail, but results must be interpreted alongside detailed fetal ultrasound findings and clinical history. A normal molecular karyotype significantly reduces but does not eliminate the possibility of a genetic condition; non-chromosomal disorders, uniparental disomy, or low-level mosaicism may still be relevant. I strongly recommend post-test genetic counseling to translate results into actionable prenatal care.”
— Dr. PRABHAKAR REDDY, Specialist Obstetrician & Gynecologist, DHA License: 61713011
⚠️ Medication Warning: Do not discontinue any prescribed medication or prenatal supplement without consulting your doctor. Aspirin, anticoagulants, or immunosuppressants may affect the procedure or interpretation.
Exclusion Criteria & Emergency Red Flags
- Active vaginal bleeding or ruptured membranes (contraindication for amniocentesis).
- Maternal fever >38.5°C or acute infectious illness prior to procedure.
- Severe oligohydramnios (amniotic fluid index <5 cm) precluding safe tap.
- Known maternal coagulopathy or use of therapeutic anticoagulation without bridging plan.
- Seek emergency care if: post-procedure you experience severe abdominal pain, persistent leaking of fluid, fever, or contractions.
Patient FAQ & Clinical Guidance
1. Why is molecular karyotyping on amniotic fluid recommended instead of NIPT?
Snippet: Molecular karyotyping of amniotic fluid provides a definitive diagnosis of submicroscopic chromosomal abnormalities that non-invasive prenatal testing (NIPT) cannot detect, with nearly 100% accuracy. NIPT is a screening test that only flags common trisomies, while this invasive test analyzes cultured fetal cells to uncover hundreds of pathogenic microdeletions and duplications, giving you a complete genomic picture for informed decision-making. تحليل النمط النووي الجزيئي للسائل الأمنيوسي يمنح تشخيصاً قاطعاً للتغيرات الصبغية الدقيقة التي لا يظهرها فحص NIPT، مما يوفر صورة جينية شاملة للجنين.
2. How safe is amniocentesis in a UAE-accredited facility, and what is the miscarriage risk?
Snippet: When performed by an experienced DHA-licensed specialist under continuous ultrasound guidance, the procedure-related miscarriage risk is less than 1 in 900, making it exceptionally safe. Our network follows Federal Decree-Law No. 41 of 2024 and CDS Law 2026 (Minors) protocols, using a single 22G spinal needle and strict aseptic technique, with continuous fetal monitoring, and all samples are processed in ISO 15189-accredited cytogenetics labs to ensure reliability. خطر الإجهاض المرتبط بالبزل الأمنيوسي في منشأة مرخصة من هيئة الصحة بدبي أقل من حالة واحدة لكل 900 إجراء، مما يجعله آمناً للغاية.
3. Will my health insurance cover this, and how do you protect my genetic data?
Snippet: Most UAE insurance plans cover molecular karyotyping for amniotic fluid when medically indicated (e.g., advanced maternal age, abnormal ultrasound, or positive screening), and we offer direct billing verification. Your genetic data is protected under the UAE Personal Data Protection Law (PDPL) and stored on encrypted servers with strict access controls; only your designated physician receives the report, and no genomic data is shared without explicit consent. بياناتكم الجينية محمية بموجب قانون حماية البيانات الشخصية الإماراتي، ولا تُشارك مع أي طرف دون موافقتكم الصريحة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians